期刊文献+

糖基化终产物对人肾小球系膜细胞β1整合素及黏着斑激酶表达的影响 被引量:4

Effects of advanced glycation end products on the expressions of β1-integrin and focal adhesion kinase(FAK)
原文传递
导出
摘要 目的观察糖基化终产物(AGEs)对人肾小球系膜细胞(HRMC)膜上β1整合素及其胞内靶点黏着斑激酶(FAK)表达的影响。方法用不同浓度的AGE-BSA干预培养的HRMC;RT-PCR法测定细胞β1整合素和FAK的mRNA水平;western Blot法检测β1整合素和FAK的蛋白表达。结果在50至400mg/L浓度范围内,AGE-BSA组β1整合素、FAK mRNA及蛋白表达均较对照组增加(P<0.05)。结论一定范围内,AGEs呈浓度依赖性上调β1整合素及其下游信号分子FAK mRNA及蛋白表达,这可能是AGEs致糖尿病肾病的一个重要机制。 Objective To investigate the effects of advanced glycation end products (AGEs) on the expressions of β1-integrin and FAK in cultured human renal mesangiai cells (HRMC). Methods HRMC were incubated with AGEs-modified bovine serum albumin (AGE-BSA), the mRNA expressions of β1- integrin and FAK in HRMC were analyzed by use of RT-PCR,and the protein expressions of β1-integrin and FAK in HRMC were determined by Western blot. Results The levels of β1-integrin and FAK mRNA and protein in HRMC incubated with AGE-BSA were significantly higher than those in normal control (P〈0. 05). Conclusions AGEs up-regulate the expression of β1-integrin and FAK in HRMC, which might have potential implications of the pathogenic mechanism of diabetic nephropathy.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第3期219-221,共3页 Chinese Journal of Diabetes
基金 江苏省教育厅高校自然科学研究项目(02KJA320001) 教育部教学研究重点项目(204051)
关键词 糖基化终产物 肾小球系膜细胞 Β1整合素 黏着斑激酶 Glycation end products, advanced Renal mesangial ceils β1-integrin Focal adhesion kinase
  • 相关文献

参考文献3

二级参考文献15

  • 1赵志涛,于晓艳,李才,苗春生,崔伦文.糖基化终末产物对大鼠肾系膜细胞基质金属蛋白酶2活性和表达的影响[J].吉林大学学报(医学版),2004,30(6):843-845. 被引量:9
  • 2顾秀锋,陆静,刘乃丰.氨基胍与葛根素对糖尿病大鼠肾脏结缔组织生长因子表达的影响[J].东南大学学报(医学版),2005,24(1):13-16. 被引量:10
  • 3DEROSA G,AVANZINI M A,GEROLDI D,et al.Matrix metalloproteinase-2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes[J].Diabetes Care,2004,27 (1):273-274.
  • 4McLENNAN S,FISHER E,MARTELL S Y,et al.Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells:possible role in diabetic nephropathy[J].Kideny Int,2000,58 (suppl 77):S81-87.
  • 5SINGH R,SONG R H,ALAVI N,et al.High glucose decrease matrix metallorpoteinase-2 activity in rat mesangia cells via transforming growth factor-beta 1[J].Exp Nephrol,2001,9:249 -257.
  • 6BARICOS W H,CORTEZ S L,DEBOISBLANC M,et al.Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation cultured human mesangial cells[J].J Am Soc Nephrol,1999,10:795.
  • 7ZIYADEH F N,HAND C.Involvement of transforming growth factor-beta and its receptors in the pathogenesis of diabetic nephrology[J].Kidney Int Suppl,1997,60:S7-11.
  • 8McLENNAN S V,WANGX Y,MORENO V,et al.Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1:implications for diabetic nephropathy[J].Endocrinology,2004,145(12):5646-5655.
  • 9孙子林,刘乃丰,刘必成,童嘉毅,王伯荣,弓玉祥,童正本,孙桂菊.糖基化终产物抗血清的制备及应用[J].中华医学检验杂志,1999,22(5):293-295. 被引量:6
  • 10黄光存,张锦生.肝星状细胞激活的细胞内信号转导[J].世界华人消化杂志,2001,9(9):1056-1060. 被引量:23

共引文献55

同被引文献22

  • 1于怀庆.辨证治疗慢性肾炎蛋白尿40例[J].光明中医,2006,21(2):31-32. 被引量:6
  • 2金虹,刘乃丰,魏芹.糖基化终产物对人肾小球系膜细胞结缔组织生长因子及纤维连接蛋白基因表达的影响[J].东南大学学报(医学版),2007,26(2):86-89. 被引量:4
  • 3魏娟,孙子林,杨涛,戴荣峰,袁杨.糖基化终产物对人肾小球系膜细胞细胞外基质金属蛋白酶促进因子基因表达的影响[J].江苏医药,2007,33(5):483-485. 被引量:2
  • 4Thomalley PJ. Advanced glycation end products in renal failure[ J]. J Ren Nutr,2006,16(3) :178 - 184.
  • 5Bohon WK, Cattran DC, Williams ME, et al. Randomized trial of an inhibitor of formation of advanced glyeation end products in diabetic nephropathy[J]. Am J Nephrol,2004, 24 : 32 - 40.
  • 6Suji G, Sivakami S. DNA damage by free radical production by aminoguanidine[ J]. Ann N Y Acad Sci,2006,1067:191 - 199.
  • 7Mason RM, Wahab NA. Extraeellular matrix metabolism in diabetic nephropathy [J]. J Am Soe Nephrol, 2003, 14 (5) : 1358-1373.
  • 8Humphries JD,Byron A, Humphries MJ. Integrin ligands at a glance[J]. Cell Science, 2006,119(19) : 3901-3903.
  • 9Basta G. Receptor for advanced glycation endproducts and ath- erosclerosis: from basic mechanisms to clinical implications[J]. Atherosclerosis, 2008,196 ( 1 ) :9-21.
  • 10Fan QL, Liao J, Kobayashi M, et al. Candesartan reduced advanced glycation end-products accumulation and diminished nitro oxidative stress in type 2 diabetic KK/Ta mice[J]. Neph- rol Dial Transplant,2004,19(12) :3012-3020.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部